ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 85 filers reported holding ALLOVIR INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,283 | -93.8% | 1,527 | -90.1% | 0.00% | – |
| Q2 2023 | $52,693 | +423.6% | 15,498 | +506.8% | 0.00% | – |
| Q1 2023 | $10,063 | -24.3% | 2,554 | -1.5% | 0.00% | – |
| Q4 2022 | $13,302 | -33.5% | 2,593 | +0.6% | 0.00% | – |
| Q3 2022 | $20,000 | -20.0% | 2,577 | -59.8% | 0.00% | – |
| Q2 2022 | $25,000 | -39.0% | 6,410 | +6.5% | 0.00% | – |
| Q1 2022 | $41,000 | -94.5% | 6,020 | -89.5% | 0.00% | – |
| Q4 2021 | $743,000 | -7.6% | 57,398 | +78.8% | 0.00% | – |
| Q3 2021 | $804,000 | -63.8% | 32,097 | -71.5% | 0.00% | -100.0% |
| Q2 2021 | $2,221,000 | +1.2% | 112,533 | +20.0% | 0.00% | 0.0% |
| Q1 2021 | $2,194,000 | +837.6% | 93,776 | +1437.6% | 0.00% | – |
| Q4 2020 | $234,000 | +875.0% | 6,099 | +608.4% | 0.00% | – |
| Q3 2020 | $24,000 | – | 861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |